IVERIC bio, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-11-13: Form 8-K; Period of report 2013-11-13; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2013-10-31: Form 8-K; Period of report 2013-10-25; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2013-11-13 | 8-K | 2013-11-13 | 2.02 Results of Operations and Financial Condition | 2.02 On November 13, 2013, Ophthotech Corporation announced its financial results for the quarter ended September 30, 2013. | a13-24192_18k.htm |
| 2013-10-31 | 8-K | 2013-10-25 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | a13-23052_18k.htm |